10-K/A XBRL

FORM 10-K/A

Company: Protagenic Therapeutics, Inc.\new
Filed: May 8, 2017
Period of Report: December 31, 2016
Accession Number: 0001437749-17-008187

View Document ↗ View on SEC.gov ↗